Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 4 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
Russia, Pakistan conclude Druzhba 2025 joint military exercises
- 16 گھنٹے قبل
49ers set to start QB Jones again; Pearsall out
- 14 گھنٹے قبل
Four candidates submit nomination papers for KP CM slot
- 11 گھنٹے قبل
Messi sits out Argentina victory in Miami friendly
- 14 گھنٹے قبل
Pakistan–Saudi Arabia defence pact: the dawn of a new era
- 15 گھنٹے قبل
China, North Korea to strengthen strategic cooperation, KCNA says
- 15 گھنٹے قبل
Taylor Swift’s ‘Life of a Showgirl’ storms UK charts, sets new records
- 16 گھنٹے قبل
US actress Diane Keaton, star of ‘Annie Hall,’ passes away at 79
- 15 گھنٹے قبل
Over 200 Afghan Taliban, Khawarij killed; 23 Pak Army soldiers martyred: ISPR
- 14 گھنٹے قبل
Pakistan 313-5 at close of first day against South Africa
- 15 گھنٹے قبل
Bitcoin extends decline to $104,782 as Trump escalates US-China trade war
- 15 گھنٹے قبل
Vegetable prices in Lahore soar once again; tomatoes reach Rs500 per kg
- 9 گھنٹے قبل
You May Like
Trending
